Cargando…
Application of DNA sequences in anti-counterfeiting: Current progress and challenges
Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing comple...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579332/ https://www.ncbi.nlm.nih.gov/pubmed/33839229 http://dx.doi.org/10.1016/j.ijpharm.2021.120580 |
_version_ | 1784812157761748992 |
---|---|
author | Sharief, Saad Asadullah Chahal, Prem Alocilja, Evangelyn |
author_facet | Sharief, Saad Asadullah Chahal, Prem Alocilja, Evangelyn |
author_sort | Sharief, Saad Asadullah |
collection | PubMed |
description | Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing complex supply chains. While RFID tags provide for an excellent alternative to current anti-counterfeiting methods, they can prove to be expensive and other routes involving nanomaterials can be difficult to encrypt. A DNA based anticounterfeiting system has significant advantages such as relative ease of synthesis and vast data storage abilities, along with great potential in encryption. Although DNA is equipped with such beneficial properties, major challenges that limit its real-world anti-counterfeiting applications include protection in harsh environments, rapid inexpensive sequence determination, and its attachment to products. This review elaborates the current progress of DNA based anti-counterfeiting systems and identifies technological gaps that need to be filled for its practical application. Progress made on addressing the primary challenges associated with the use of DNA, and potential solutions are discussed. |
format | Online Article Text |
id | pubmed-9579332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95793322022-10-19 Application of DNA sequences in anti-counterfeiting: Current progress and challenges Sharief, Saad Asadullah Chahal, Prem Alocilja, Evangelyn Int J Pharm Article Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing complex supply chains. While RFID tags provide for an excellent alternative to current anti-counterfeiting methods, they can prove to be expensive and other routes involving nanomaterials can be difficult to encrypt. A DNA based anticounterfeiting system has significant advantages such as relative ease of synthesis and vast data storage abilities, along with great potential in encryption. Although DNA is equipped with such beneficial properties, major challenges that limit its real-world anti-counterfeiting applications include protection in harsh environments, rapid inexpensive sequence determination, and its attachment to products. This review elaborates the current progress of DNA based anti-counterfeiting systems and identifies technological gaps that need to be filled for its practical application. Progress made on addressing the primary challenges associated with the use of DNA, and potential solutions are discussed. Elsevier B.V. 2021-06-01 2021-04-09 /pmc/articles/PMC9579332/ /pubmed/33839229 http://dx.doi.org/10.1016/j.ijpharm.2021.120580 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sharief, Saad Asadullah Chahal, Prem Alocilja, Evangelyn Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title | Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title_full | Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title_fullStr | Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title_full_unstemmed | Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title_short | Application of DNA sequences in anti-counterfeiting: Current progress and challenges |
title_sort | application of dna sequences in anti-counterfeiting: current progress and challenges |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579332/ https://www.ncbi.nlm.nih.gov/pubmed/33839229 http://dx.doi.org/10.1016/j.ijpharm.2021.120580 |
work_keys_str_mv | AT shariefsaadasadullah applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges AT chahalprem applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges AT alociljaevangelyn applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges |